Category: Forbes

Cigna To Accelerate Partnership Strategy In 2020

Cigna CEO David Cordani said partnerships like its decision to sell new health plans with Oscar Health and its alliance with the pharmacy benefit manager Prime Therapeutics will escalate in 2020.

Drugmaker BioMarin Seeks New CFO Amid Coming Release Of Potentially Costliest Drug In The World

BioMarin Pharmaceutical, which is vying to release the most expensive drug in the world at somewhere between $2 million and $3 million a dose, announced Tuesday the departure of its chief financial officer.

Amid Real Fear, Some Good News About Our Understanding Of The Coronavirus

Amid the real fear and uncertainty there is some better news.

Profitability in the Health Care Market Has Never Been Better

Health care industry profits have never been better while those in the Obamacare individual health insurance market suffer with extraordinarily high premiums.

The Five Times Susan Collins Has Actually Been A Swing Vote

The Maine senator is expected to vote to acquit Donald Trump.

Coronavirus Taking Its Toll On The Auto Industry–And It May Get Worse

The ongoing outbreak in China is playing havoc with automotive production and the worst may be yet to come.

Bill And Melinda Gates Donate $100 Million To Coronavirus Vaccine Research

More than 24,000 people have been infected with coronavirus and 490 have died.

Walgreens Shuffles Senior Management To Boost U.S. Pharmacies

Walgreens Boots Alliance promoted Richard Ashworth, a veteran of the company’s U.S. pharmacy operations, to become President of Walgreens amid a critical transition for the iconic drugstore chain.

As Humana Invests In Clinics, Medicare Business Adds 523K Seniors

Humana’s chief executive said the company will add another 270,000 to 330,000 seniors to its Medicare Advantage plans in 2020 on top of the “more than a half million” added in 2019 as more seniors flock to private plans that contract with the governmen…

Seven Synthetic Biology Companies In The Fight Against Coronavirus

Coronavirus has put a lot of attention on global biotech’s ability to respond to deadly new diseases. These are the synthetic biologists who are applying cutting-edge tools and technology to go from detection to cure with unprecedented speed and scale.